Foundation Medicine touts concordance ahead of FDA ruling on liquid biopsy test
The company filed for FDA approval of the FoundationOne Liquid test at the end of December. Data from a clinical trial presented at an October conference showed the test had a strong ability to detect a genetic driver mutation in lung cancer.
